Bolt Biotherapeutics, Inc. Share Price

Bolt Biotherapeutics, Inc. Share Price

NASDAQ: BOLT | Micro Cap
$6.31
-$0.24 (-3.66%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Bolt Biotherapeutics, Inc. Stock Performance

Open
$6.45
Prev. Close
$6.55
Circuit Range
N/A
Day Range
$6.45 - $6.50
Year Range
$3.14 - $7.53
Volume
999
Average Traded
$6.48

Bolt Biotherapeutics, Inc. Share Price Today

As of 30 October 2026, Bolt Biotherapeutics, Inc.'s share price is $6.31. The stock opened at $6.45, compared to its previous close of $6.55. During today's trading session, Bolt Biotherapeutics, Inc.'s share price traded between $6.45 and $6.50, with an average price of $6.47. Over the past 52 weeks, the stock has recorded a high of $7.53 and a low of $3.14. In terms of performance, Bolt Biotherapeutics, Inc.'s share price has risen by 32.01% over the last six months and is up 7.68% on a year-on-year basis.

Bolt Biotherapeutics, Inc. Share Price Chart

Line chart of the Bolt Biotherapeutics, Inc. price trend over the selected period. The price fell overall, ranging from 6.31 to 6.58, ending at 6.31.
$6.45$6.50
L
Show Current Price
H

Bolt Biotherapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$11.80M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-12.19
Revenue (TTM)
$7.70B
Return On Equity (TTM)
-227.37%
Profit Margin
-433.51%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-8.12%

Bolt Biotherapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$2.17$2.50$0.03$0.01
Net Profit-$7.14-$6.63-$7.24-$7.72
Net Profit Margin-329.03%-265.20%-24133.33%-77200.00%
Income ChangeN/A7.14%-9.20%-6.63%

Bolt Biotherapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$5.73$7.88$7.69$7.70
Net Profit-$88.10-$69.20-$63.12-$33.38
Net Profit Margin-1537.52%-878.17%-820.81%-433.51%
Income ChangeN/A21.45%8.79%47.12%

About Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics Inc is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. The company is focused on the clinical development of BDC-4182, its claudin 18.2 ISAC. Its other pipeline programs include CEA ISAC program a Boltbody ISAC targeting carcinoembryonic antigen cell adhesion molecule 5, or CEA; PD-L1 ISAC utilizes a novel human anti-PD-L1 antibody conjugated to a next-generation TLR7/8 agonist payload via a non-cleavable linker; and BDC-3042, its dectin-2 agonist antibody program, developed to repolarize critical cells in the tumor microenvironment known as tumor associated macrophages. It operates in single segment.

Bolt Biotherapeutics, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$3.72
$6.50
+78.93%
Sep 2026
$3.69
$3.63
-6.68%
Aug 2026
$3.84
$3.89
-2.87%
Jul 2026
$3.83
$4.00
+4.03%
Jun 2026
$5.48
$3.85
-26.39%
May 2026
$4.82
$5.23
+9.41%
Apr 2026
$4.51
$4.78
+16.02%
Mar 2026
$4.54
$4.12
-7.62%
Feb 2026
$5.76
$4.46
-27.00%
Jan 2026
$6.02
$6.11
+12.94%
Dec 2025
$5.00
$5.41
+11.55%
Nov 2025
$5.51
$4.85
-17.24%

BOLT Share Price FAQs